Comments*

 
  • Events 

    Thursday, September 8, 2016 | 9:00 AM - 5:00 PM

    Targeting Inflammation and Podocytopathy in Chronic Kidney Disease

    Speakers: Hans-Joachim Anders (University of Munich), Caroline Fox (Merck Research Laboratories), John Cijiang He (Icahn School of Medicine at Mount Sinai), Matthias Kretzler (University of Michigan), Kevin V. Lemley (University of Southern California), Jochen Reiser (Rush University Medical Center), Katalin Susztak (University of Pennsylvania), and Roger C. Wiggins (University of Michigan)

    Accumulating evidence supports a role for renal inflammation and podocytopathy in pathogenesis and progression of chronic kidney disease. This symposium will delve into the mechanisms underlying this pathology.

    Friday, September 9, 2016 | 12:00 PM - 4:00 PM

    Protein Engineering and Protein Therapeutics

    Speakers: Shohei Koide (NYU Langone Medical Center), Jonathan R. Lai (Albert Einstein College of Medicine), Jim Wells (University of California San Francisco), and Manoj Charati (Pfizer)

    This symposium will highlight state-of-the-art technologies in protein and antibody engineering, and antibody-drug conjugates. The implementation of these methods to specific diseases, and unique research tools, will also be discussed.

    Friday, September 16, 2016 | 8:30 AM - 6:00 PM

    Big Data, Consumer Technology, and the Obesity Epidemic: Emerging Science and Ethical Considerations

    Speakers: Lori B. Andrews (Illinois Institute of Technology), Gary Bennett (Duke University), Barbara Millen (Healthmain), Tooraj Mirshahi (Geisinger Clinic), Satchidananda Panda (SALK Institute), Ruth E. Patterson (University of California San Diego), Michael Price (Georgia State University), Karandeep Singh (University of Michigan), and Nicholas Tatonetti (Columbia University)

    Researchers, health professionals, and a growing wellness-conscious public use technology to monitor health status. Big Data harnessed from this technology have created a foundation for focused research targeting obesity, but at what cost?

    September 21 - 23, 2016

    13th Key Symposium 2016: Bioelectronic Medicine — Technology Targeting Molecular Mechanisms

    Featuring: Peder Olofsson (Karolinska Institutet) and Kevin J. Tracey (The Feinstein Institute for Medical Research)

    Bioelectronic medicine, a new discipline aimed at interfacing electronics with cells to target molecular mechanisms, is at the epicenter of healthcare, technology, and science. This symposium will advance the technological promise of bioelectronics.

    Friday, October 7, 2016 | 9:00 AM - 5:00 PM

    Advances in the Neurobiology of Mental Illness

    Mental illness causes debilitating consequences on quality of life for individuals, families, and society. This symposium explores avenues for translating these discoveries about the neurobiology of a spectrum of mental illnesses into new treatments.

  • Past Events

    Wednesday, July 13, 2016 | 9:00 AM - 5:00 PM

    MicroRNAs: A Gene Silencing Mechanism with Therapeutic Implications

    Keynote Speaker: David Bartel (Whitehead/MIT/HHMI)
    Speakers: Paul Grint (Regulus Therapeutics), David S Hong (The University of Texas MD Anderson Cancer Center ), Daniel J Siegwart (University of Texas Southwestern Medical Center), Frank Slack (BIDMC Cancer Center/Harvard Medical School), James W Welsh (The University of Texas MD Anderson Cancer Center)

    miRNAs play critical roles in regulating gene expression. This symposium will present up-to-date basic, translational, and clinical research addressing the biology of miRNA and their promise as a therapeutic target.

    Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM

    Multiple Sclerosis: Diagnostic and Treatment Frontiers

    Keynote Speaker: Giancarlo Comi (Università Vita-Salute San Raffaele)

    Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.

    Tuesday, June 21, 2016 | 8:30 AM - 5:00 PM

    Surgery and Cognition: Delirium, Cognitive Decline, and Opportunities to Protect the Brain

    Keynote Speaker: Sharon Inouye (Harvard Medical School)

    This meeting will convene leading scientists and physicians to discuss the challenges and opportunities to create biomarkers and therapeutics for these patients who are vulnerable to delirium, cognitive decline, and dementia following surgery.

    Monday, June 13, 2016 | 10:00 AM - 3:30 PM

    2016 Ross Prize in Molecular Medicine: Resolution of Inflammation

    Speakers: Ruslan M. Medzhitov (Yale School of Medicine, Howard Hughes Medical Institute), Mauro Perretti (The William Harvey Research Institute, Queen Mary University of London), Charles N. Serhan (Brigham and Women's Hospital & Harvard Medical School), Lars Klareskog (Karolinska Institutet), and Kevin J. Tracey (The Feinstein Institute for Medical Research)

    This symposium will honor Dr. Charles N. Serhan, the recipient of the 2016 Ross Prize in Molecular Medicine, for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases.

  • Publications 

    eBriefing

    Sohn Conference: Pediatric Cancer in a Post-genomic World

    Keynote Speakers: Richard Gilbertson (Cambridge Cancer Centre, University of Cambridge, UK) and Craig B. Thompson (Memorial Sloan Kettering Cancer Center)

    This eBriefing covers the latest research on pediatric cancers.

    eBriefing

    Epigenetics: Cancer and Beyond

    Organizers: Donald McCaffery (Resverlogix Corp.), Norman Wong (Resverlogix Corp.), Sarah Zapotichny (Resverlogix Corp.), George Zavoico (Jones Trading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
    Keynote Speaker: Craig B. Thompson (Memorial Sloan Kettering Cancer Center)

    Epigenetic abnormalities contribute to tumorigenesis and various diseases beyond cancer. This eBriefing describes recent progress in validating the therapeutic potential of small molecule inhibitors targeting epigenetic marks.

    Annals

    Special Issue: Annals Reports

    Edited by Annals of the New York Academy of Sciences editorial staff

    This Annals issue presents a meeting report on mobile health technology in clinical trials and five original research articles discussing topics related to β-thalassemia major, Alzheimer's disease, hematopoiesis, hepatosteatosis, and downbeat nystagmus.

    Volume 1375

    Annals

    Special Issue: Countermeasures Against Chemical Threats I

    Edited by Jeffrey D. Laskin (Rutgers University School of Public Health)

    Chemical threats, both accidental and deliberate, are of critical concern globally. This, the first of two Annals issues devoted to this topic, presents 23 papers that discuss various countermeasures against chemical threats.

    Volume 1374